Piramal Pharma Limited PPLPHARMA

Latest filings

• General25 18 Sept, 19:51 · NSE
  Disclosure under Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015 ESG Rating
• General25 18 Sept, 19:39 · BSE
  Please refer attached file
• General25 14 Sept, 19:57 · NSE
  Disclosure under Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015 FDA Inspection
• General25 14 Sept, 19:50 · BSE
  Please refer attached file
• Routine15 8 Sept, 15:37 · NSE
  Intimation of Schedule of Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Routine15 8 Sept, 15:33 · BSE
  Please refer attached file
• General25 3 Sept, 14:28 · BSE
  Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating
• Insider / SAST45 26 Aug, 17:21 · BSE
  Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
• General25 24 Aug, 17:01 · BSE
  Piramal Pharma Ltd - 543635 - Sustainability Report Of Piramal Pharma Limited For The Financial Year 2025-26
• M&A73 18 Aug, 11:34 · BSE
  Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Acquisition

Shown 15 minutes after publication. Real time with Pro.